New biotech incubator opens at Berkeley

UC Berkeley is getting into the biotech incubator game. Hoping to achieve some of the success of UC San Francisco's incubator, which has helped spawn 28 companies, the university is cutting the ribbon on its QB3 [email protected] The first tenant: Apersys, which has taken 100 square feet of space to start pursuing its dream of developing a new way to "grow nerve cells used in biology experiments," according to the San Francisco Business Times. Report

Suggested Articles

After delivering a "positive surprise" in December, Biogen is painting a fuller picture of its lupus drug.

A new CRISPR technique neutralizes SARS-CoV-2 by scrambling the virus' genetic code. It could prove useful for fighting other viruses, like influenza.

The deal, which follows a bidding war with AcelRx, gives Melinta another approved antibiotic and potentially complementary R&D expertise.